Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

Kalorama Information
January 1, 2005
599 Pages - SKU: KLI1035014
Countries covered: Global

Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

  enlarge
The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come.

There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six technologies examined in this study are:

  • Antisense
  • Ribonucleic acid inhibition (RNAi)
  • Gene therapy
  • Nucleoside analogs
  • Ribozymes, and
  • Aptamers

This report focuses on the application of nucleic acid-based therapeutics to the prevention and treatment of various diseases and disorders:

  • Cancer
  • Rheumatoid arthritis
  • Diabetes (Types I and II)
  • Cardiovascular disease (hypertesion, Coronary artery disease, and congestive heart failure)
  • Autoimmune diseases (psoriasis, lupus erythematosus, psoriatic arthritis, and scleroderma)
  • Neurological Diseases (peripheral neuropathies, Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, severe traumatic brain injury, and spinal cord injury)
  • Viral Diseases, and
  • Miscellaneous conditions

The report examines the options that these new therapeutics present, the progress that is being made in these fields, and the motivations for broader pharmaceutical industry involvement in these markets. The major market effects of nucleic acid-based therapeutics are seen as having the potential to significantly impact the seven major world healthcare markets over the next ten years. The trends selected in conjunction with the growing interest in preventive medicine alone, and gene vaccines specifically, and the application to current health priorities present the most informative picture of advances in this field and the markets that result.

Market analysis for this report considers the various applications of nucleic acid-based therapeutics rather than the markets for specific products in the seven major world healthcare markets:

  • United States
  • Japan
  • Germany
  • France
  • United Kingdom
  • Italy, and
  • Spain

The analysis presented in this report is based on data from a combination of company, government, industry, institutional, and private sources. It includes information from extensive literature reviews, as well as in-depth interviews and discussions with experts in the field, including medicinal chemists, experts in genetics and genomics, medical professionals, research scientists, business development managers, and marketing managers.




More Research & Development reports by Kalorama Information

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition by Kalorama Information
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process.This Kalorama Information ...
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 by Kalorama Information
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to ...
The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs) by Kalorama Information
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The ...
The World Market for Pain Management Drugs and Devices by Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain ...
See all reports like this >>

More Global Research & Development reports

Global Hepatitis C Market 2014-2018 by TechNavio - Infiniti Research Ltd.
About Hepatitis CHepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other ...
Global Asthma Market 2014-2018 by TechNavio - Infiniti Research Ltd.
About Asthma and its CategoriesAsthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a ...
Global Multiple Sclerosis Drugs Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Multiple Sclerosis Drugs Market 2014-2018 TechNavio recognizes the following companies as the key players ...
Global Cytomegalovirus Retinitis Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Cytomegalovirus Retinitis Market 2014-2018 TechNavio recognizes the following companies as the key players in ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 3,500  
    Hard Copy Mail Delivery  USD 3,500  
    Global Site License  USD 7,000  
    Online Download plus 1 Hard Copy  USD 3,800  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!